aVenture is in Alpha: aVenture recently launched early public access to our research product. It's intended to illustrate capabilities and gather feedback from users. While in Alpha, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to temporarily present this information to showcase the product's potential, but you should not yet rely upon it for your investment decisions.
aVenture is in Alpha: aVenture recently launched early public access to our research product. It's intended to illustrate capabilities and gather feedback from users. While in Alpha, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to temporarily present this information to showcase the product's potential, but you should not yet rely upon it for your investment decisions.
© aVenture Investment Company, 2025. All rights reserved.
44 Tehama St, San Francisco, CA 94105
Privacy Policy
aVenture Investment Company ("aVenture") is an independent venture capital research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals.
While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision.
aVenture does not offer investment advisory services and is not registered as an investment adviser. The data provided by aVenture does not constitute recommendations or advice, whether by methodology or a statement written by a staff member of aVenture.
Links to external websites do not imply endorsement or affiliation with aVenture. References or links to providers offering the ability to invest in a primary or secondary transaction in a company are for convenience purposes only. They are not solicitations or offers to buy or sell an investment. Remember that past performance does not guarantee future results, and venture capital and private assets should be a contributory part of a diversified portfolio.
MedZoomer: Your on-demand platform for doorstep prescription delivery.
Founded with the mission to revolutionize medication access, MedZoomer is an on-demand prescription delivery platform that ensures medications are delivered from pharmacies directly to patients' doorsteps. The company aims to provide a seamless, secure, and convenient service for patients, allowing them to receive their prescriptions without leaving their homes. MedZoomer partners with pharmacies to facilitate this process, ensuring that all deliveries are handled by HIPAA-certified couriers to maintain patient confidentiality and safety.
MedZoomer has garnered attention for its innovative approach to healthcare logistics, attracting notable investors and industry experts. The platform has achieved significant milestones, including expanding its network of pharmacy partners and enhancing its delivery infrastructure to cover a broader geographic area. By addressing a critical need in the healthcare system, MedZoomer has made a substantial impact on improving medication adherence and patient convenience, setting a new standard for prescription delivery services.
Operating Status
Active
Main Product(s)
Prescription Delivery
Technology
Logistics
Tags
Healthtech, API
Model Types
SaaS, Platform
Revenue Type(s)
Transactional
Customer Type(s)
Consumers
Geographic Exposure
United States
When was Medzoomer founded?
Medzoomer was founded in 2019.
Where is Medzoomer’s headquarters located?
Medzoomer’s headquarters is located in Middletown, DE, US.
How many employees does Medzoomer have?
Medzoomer has 24 employees as of Feb 5, 2024.
How much has Medzoomer raised to-date?
As of July 05, 2023, Medzoomer has raised a total of $3.4M (USD) since Aug 24, 2023.
Add Comparison
Total Raised to Date
$3.4M
USD
Last Update Aug 24, 2023
Total Employees Over Time
24
As of Feb 2024
Medzoomer Address
600 N. Broad Street
Suite 5
Middletown,
Delaware
19709
United States
Source(s): This page includes data and analysis provided by the company, OpenAI, and our research analysts